Correction: Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage
Journal of Translational Medicine volume 21, Article number: 315 (2023)
Correction: Journal of Translational Medicine (2013) 11:29 https://doi.org/10.1186/1479-5876-11-29
Since the publication of our article , it has come to our attention that the legend to Fig. 1(A) left panel did not acknowledge that this figure had been adapted from a published source. The legend to Fig. 1(A) should read as follows:
(A) The levels of CSE1L expression in B16-EV, B16-CSE1L, COLO-EV, and COLO-CSE1L cells were assayed by immunoblotting with anti-CSE1L antibody. The β-actin levels were assayed as a control. The invasive ability of the cells was analyzed by in vitro invasion assays using chemotaxis chambers, as described in “Materials and Methods”. The left panel is adapted with permission from Fig. 5C in Liao CF, Luo SF, Li LT, Lin CY, Chen YC, Jiang MC. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. J Exp Clin Cancer Res. 2008; 27:15. https://jeccr.biomedcentral.com/articles/10.1186/1756-9966-27-15. Copyright © 2008, Liao et al.; licensee BioMed Central Ltd.
Tai C-J, Su T-C, Jiang M-C, Chen H-C, Shen S-C, Lee W-R, Liao C-F, Chen Y-C, Lin S-H, Li L-T, Shen K-H, Yeh C-M, Yeh K-T, Lee C-H, Shih H-Y, Chang C-C. Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage. J Transl Med. 2013;11:29. https://doi.org/10.1186/1479-5876-11-29.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tai, CJ., Su, TC., Jiang, MC. et al. Correction: Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage. J Transl Med 21, 315 (2023). https://doi.org/10.1186/s12967-023-04148-w